228 related articles for article (PubMed ID: 37309281)
1. Variations in pleural microbiota and metabolic phenotype associated with malignant pleural effusion in human lung adenocarcinoma.
Huang D; Zhuo J; Ye C; Su X; Chen Y; Li C; Lin L; Liu L; Zhao H; Luo T; Ren Q; Wu J; Cai S; Dong H
Thorac Cancer; 2023 Jul; 14(21):2045-2056. PubMed ID: 37309281
[TBL] [Abstract][Full Text] [Related]
2. Metabolic and lipidomic characterization of malignant pleural effusion in human lung cancer.
Yang Z; Song Z; Chen Z; Guo Z; Jin H; Ding C; Hong Y; Cai Z
J Pharm Biomed Anal; 2020 Feb; 180():113069. PubMed ID: 31884394
[TBL] [Abstract][Full Text] [Related]
3. Pleural fluid microbiota as a biomarker for malignancy and prognosis.
Kwok B; Wu BG; Kocak IF; Sulaiman I; Schluger R; Li Y; Anwer R; Goparaju C; Ryan DJ; Sagatelian M; Dreier MS; Murthy V; Rafeq S; Michaud GC; Sterman DH; Bessich JL; Pass HI; Segal LN; Tsay JJ
Sci Rep; 2023 Feb; 13(1):2229. PubMed ID: 36755121
[TBL] [Abstract][Full Text] [Related]
4. Microbiome profile associated with malignant pleural effusion.
Shojaee S; Sharma A; Gottel N; Sanchez T; Gilbert JA; Rahman NM
PLoS One; 2020; 15(5):e0232181. PubMed ID: 32384089
[TBL] [Abstract][Full Text] [Related]
5. Exosomal MicroRNA Expression Profiling in Patients with Lung Adenocarcinoma-associated Malignant Pleural Effusion.
Tamiya H; Mitani A; Saito A; Ishimori T; Saito M; Isago H; Jo T; Yamauchi Y; Tanaka G; Nagase T
Anticancer Res; 2018 Dec; 38(12):6707-6714. PubMed ID: 30504380
[TBL] [Abstract][Full Text] [Related]
6. Combined Methylation of
Zhong Q; Wang Y; Liang C; Wei F; She B
Discov Med; 2023 Oct; 35(178):845-852. PubMed ID: 37811622
[TBL] [Abstract][Full Text] [Related]
7. Use of Platelet Parameters in the Differential Diagnosis of Lung Adenocarcinoma-Associated Malignant Pleural Effusion and Tuberculous Pleural Effusion.
Ai L; Li J; Ye T; Wang W; Li Y
Dis Markers; 2022; 2022():5653033. PubMed ID: 35531478
[TBL] [Abstract][Full Text] [Related]
8. Differences in
Xie T; Wang Q; Gao J; He K; Yu J
Ann Clin Lab Sci; 2024 Mar; 54(2):201-210. PubMed ID: 38802158
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic value of pleural interleukin 17 and carcinoembryonic antigen in lung cancer patients with malignant pleural effusions.
Xu CH; Zhan P; Yu LK; Zhang XW
Tumour Biol; 2014 Feb; 35(2):1599-603. PubMed ID: 24072496
[TBL] [Abstract][Full Text] [Related]
10. Comparative study of EGFR mutations detected in malignant pleural effusion, plasma and tumor tissue in patients with adenocarcinoma of the lung.
Wang S; Chen H; Zhong J; Qin H; Bai H; Zhao J; Wang J
Lung Cancer; 2019 Sep; 135():116-122. PubMed ID: 31446983
[TBL] [Abstract][Full Text] [Related]
11. Quantitative proteomics revealed protein biomarkers to distinguish malignant pleural effusion from benign pleural effusion.
Dong T; Liang Y; Chen H; Li Y; Li Z; Gao X
J Proteomics; 2024 May; 302():105201. PubMed ID: 38768894
[TBL] [Abstract][Full Text] [Related]
12. Microarray expression profile and analysis of circular RNA regulatory network in malignant pleural effusion.
Wen Y; Wang Y; Xing Z; Liu Z; Hou Z
Cell Cycle; 2018; 17(24):2819-2832. PubMed ID: 30563416
[TBL] [Abstract][Full Text] [Related]
13. Integrated microbiome and metabolome analysis reveals a novel interplay between commensal bacteria and metabolites in colorectal cancer.
Yang Y; Misra BB; Liang L; Bi D; Weng W; Wu W; Cai S; Qin H; Goel A; Li X; Ma Y
Theranostics; 2019; 9(14):4101-4114. PubMed ID: 31281534
[No Abstract] [Full Text] [Related]
14. Diagnostic value of tumor markers for lung adenocarcinoma-associated malignant pleural effusion: a validation study and meta-analysis.
Feng M; Zhu J; Liang L; Zeng N; Wu Y; Wan C; Shen Y; Wen F
Int J Clin Oncol; 2017 Apr; 22(2):283-290. PubMed ID: 27990560
[TBL] [Abstract][Full Text] [Related]
15. Single-cell transcriptomics reveal metastatic CLDN4+ cancer cells underlying the recurrence of malignant pleural effusion in patients with advanced non-small-cell lung cancer.
Zhang X; Wang X; Wen Y; Chen S; Zhou C; Wu F
Clin Transl Med; 2024 Apr; 14(4):e1649. PubMed ID: 38629624
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic value of soluble receptor-binding cancer antigen expressed on SiSo cells and carcinoembryonic antigen in malignant pleural effusion in patients with lung cancer.
Xu CH; Hao KK; Yu LK; Zhang XW
Asia Pac J Clin Oncol; 2015 Mar; 11(1):28-33. PubMed ID: 24720371
[TBL] [Abstract][Full Text] [Related]
17. Cell-free DNA methylation analysis as a marker of malignancy in pleural fluid.
Bixby B; Vrba L; Lenka J; Oshiro MM; Watts GS; Hughes T; Erickson H; Chopra M; Knepler JL; Knox KS; Jarnagin L; Alalawi R; Kala M; Bernert R; Routh J; Roe DJ; Garland LL; Futscher BW; Nelson MA
Sci Rep; 2024 Feb; 14(1):2939. PubMed ID: 38316884
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of bevacizumab combined with chemotherapy in lung adenocarcinoma-induced malignant pleural effusion.
Tao H; Meng Q; Li M; Shi L; Tang J; Liu Z
Thorac Cancer; 2018 Feb; 9(2):298-304. PubMed ID: 29297985
[TBL] [Abstract][Full Text] [Related]
19. Thymidine kinase 1 concentration in pleural effusion is a diagnostic marker and survival predictor for malignant pleural effusion.
Tian T; Li J; Hu W; Sun C; Zhou J
J Clin Lab Anal; 2019 Jul; 33(6):e22901. PubMed ID: 30985967
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of pleural effusion Krebs von den Lungen-6 in malignant pleural effusion of patients with non-small cell lung cancer.
Wang J; Ling L; Chen S; Chou L; Wang Y; Hu L
Lab Med; 2024 May; 55(3):271-276. PubMed ID: 37566516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]